This content is from: Home

Cravath recruits Kappos as corporate partner

David Kappos, who left his job as director of the USPTO last Friday, has joined Cravath Swaine & Moore’s New York office as a partner in the firm's corporate practice

He will be part of Cravath’s corporate department and will handle both corporate and IP matters. Notably, although Cravath’s litigation practice includes IP litigation, the firm does not have a separate IP department. David Kappos

Kappos, who was appointed USPTO director by President Barack Obama in 2009, announced in November 2012 that he would step down at the end of January.

His achievements at the USPTO include overseeing the implementation of the America Invents Act (AIA) and reducing the patent backlog by 20%, despite a 5% annual increase in applications.

Before joining the USPTO, Kappos was vice president and assistant general counsel for intellectual property for IBM, the owner of the most patents in the world. He joined IBM in 1983 as a development engineer and spent more than 25 years at the company.

Former USPTO deputy director Teresa Stanek Rea has taken over as the Office’s acting director. Speaking at AIPLA’s Mid-Winter Institute conference in Tampa on Saturday, Rea described Kappos as a “true visionary” who made “dramatic changes” to the patent office.

In an interview with Managing IP in November 2012, Judge Paul Michel, retired chief judge of the Federal Circuit, described Kappos as "the strongest USPTO leader we have had in at least a generation".

In a statement, Kappos said he was “thrilled” to be joining Cravath.

“I was fortunate to work closely with Cravath on many intellectual property matters over the years as a client at IBM, and I developed an extremely high regard for the firm's unique ability to achieve the best possible results handling the most complex and important corporate and contested IP issues,” said Kappos.





The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.

Related

Instant access to all of our content. Membership Options | 30 Day Trial